Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update

20 Apr 2022 07:00

RNS Number : 6551I
Biome Technologies PLC
20 April 2022
 

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310.

 

20 April 2022

 

 

Biome Technologies plc

 

("Biome", "the Company" or "the Group")

 

Trading Update

 

 

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, today provides an unaudited Trading Update for the quarter ended 31 March 2022.

 

Group revenues for the quarter ended 31 March 2022 were in line with management expectations at £1.1m (Q1 2021: £1.4m).

 

Bioplastics Division

 

The division's revenues for Q1 were £1.0m (Q1 2021: £1.2m). Further substantial revenue growth from this division is anticipated during 2022 as some of the previously reported logistics issues clear and a number of important customer positions accelerate or move into a commercial phase.

 

Stanelco RF Technologies Division

 

Revenues in the RF Technologies division in Q1 were £0.1m (Q1 2021: £0.2m). The division has a strong orderbook, announced previously, that are currently in production and are expected to deliver revenue both in Q2 and into the second half of the year. A solid pipeline of opportunities from our target markets are under discussion and continued good order intake is encouraging.

 

Group Performance

 

The Group had a cash balance as at 31 March 2022 of £0.9m (31 March 2021: £1.6m). As at 19 April 2022, the Group had cash of £0.9m and no debt.

 

Group Outlook

 

The Board's view of the Group's performance remains in line with current market expectations.

 

 

-Ends-

 

 

For further information please contact: Biome Technologies plc

 

Paul Mines, Chief Executive Officer

Rob Smith, Chief Financial Officer

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Sales and Corporate Broking)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

The Group comprises two divisions, Biome Bioplastics Limited ("Bioplastic") and Stanelco RF Technologies Limited ("RF Technologies").

Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil- based polymers.

Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.

www.biometechnologiesplc.com www.biomebioplastics.com and www.thinkbioplastic.com www.stanelcorftechnologies.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKCBBABKDDQD
Date   Source Headline
14th Jun 201012:31 pmRNSResult of Meeting
14th Jun 20107:00 amRNSResult of the Firm Placing, Placing and Open Offer
27th May 20104:15 pmRNSPublication of Prospectus
27th May 20107:00 amRNSFirm Placing and Placing and Open Offer
25th May 20104:40 pmRNSSecond Price Monitoring Extn
25th May 20104:35 pmRNSPrice Monitoring Extension
21st May 20104:40 pmRNSSecond Price Monitoring Extn
21st May 20104:35 pmRNSPrice Monitoring Extension
30th Apr 20104:40 pmRNSSecond Price Monitoring Extn
30th Apr 20104:35 pmRNSPrice Monitoring Extension
30th Apr 201010:36 amRNSAnnual Report and Accounts
29th Apr 20107:01 amRNSInterim Management Statement
29th Apr 20107:00 amRNSPreliminary Results
19th Apr 20107:00 amRNSUpdate re Novamont S.p.A infringement claims
16th Apr 20107:00 amRNSAnnual Information Update
17th Feb 20108:00 amRNSBiome Bioplastics new HT bioplastic
25th Jan 201010:30 amRNSStanelco re-brands bioplastics business
9th Dec 20098:00 amRNSOrders for Fibre Optics systems in Asia
3rd Dec 20097:00 amRNSStatement re share price movement
25th Nov 20094:40 pmRNSSecond Price Monitoring Extn
25th Nov 20094:35 pmRNSPrice Monitoring Extension
9th Nov 200910:06 amRNSHolding(s) in Company
6th Nov 20097:00 amRNSInterim Management Statement
21st Oct 20093:17 pmRNSHolding(s) in Company
20th Oct 20094:35 pmRNSPrice Monitoring Extension
8th Sep 20094:45 pmRNSHolding(s) in Company
4th Sep 20094:35 pmRNSPrice Monitoring Extension
3rd Sep 20094:40 pmRNSSecond Price Monitoring Extn
3rd Sep 20094:35 pmRNSPrice Monitoring Extension
28th Aug 20097:00 amRNSInterim Results
13th Aug 20094:40 pmRNSSecond Price Monitoring Extn
13th Aug 20094:35 pmRNSPrice Monitoring Extension
7th May 20097:00 amRNSDirectors' Dealing
24th Apr 20091:42 pmRNSResult of Annual General Meeting
24th Apr 20097:00 amRNSInterim Management Statement
7th Apr 20097:00 amRNSAnnual Information Update
2nd Apr 20092:01 pmRNSDirector/PDMR Shareholding
1st Apr 20097:00 amRNSChange of Adviser
30th Mar 20095:36 pmRNSAnnual Report and Accounts and Notice of AGM
26th Mar 20094:35 pmRNSPrice Monitoring Extension
26th Mar 20097:00 amRNSPreliminary Results
19th Dec 20087:01 amRNSDirectorate Change
19th Dec 20087:00 amRNSDirectorate Change
7th Nov 20087:00 amRNSInterim Management Statement
10th Oct 200811:14 amRNSDirector/PDMR Shareholding
2nd Sep 200812:02 pmRNSHolding(s) in Company
29th Aug 20087:00 amRNSInterim Results
22nd Aug 20081:36 pmRNSHolding(s) in Company
30th Jul 20089:02 amRNSHolding(s) in Company
11th Jul 20087:00 amRNSNotifiable Interest

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.